Painkiller Remoxy (Oxycodone) May Still See An NDA Refiling By Mid-2015 (PTIE) – Seeking…

Summary

  • Pfizer announced it was returning the Remoxy rights to the initial filers of the NDA, Pain Therapeutics, the shares of which sank 53% on the news.
  • However, a search on ClinicalTrials.gov reveals that Pfizer has completed all the necessary Phase I bioequivalence trials required to address the FDA‘s last Complete Response Letter.
  • That may be enough to attract a new partner for the (more…)